ATG5 and in situ carcinoma: A significant increase in ATG5 concentrations was observed in the kidneys of the CIS-treated Gal-3 wild-type mice compared to Gal-3 wild-type sham control mice, indicating statistical significance (p < 0.001) (Figure 10E).